BackCidara Therapeutics Overview

Cidara Therapeutics Operating Income

Operating Income for CDTX.

Quarterly Operating Income

$-88628000.00
↑ 409.53% YoY

As of Sep 30, 2025

Annual Operating Income (TTM)

$-199398000.00
↑ 340.56% YoY

Trailing 12 months ending Sep 30, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin